Cash for sobriety: new trial aims to keep transplant patients off alcohol

NCT ID NCT06304467

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a behavioral program called contingency management for people who have had a liver transplant due to alcohol-related liver disease and have started drinking again. Participants get rewards like gift cards for staying alcohol-free, measured by urine and blood tests. The goal is to see if this approach increases the number of sober days and improves quality of life.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
contingency management (behavioral therapy with monetary rewards)
What this could lead to
If it works, this could offer a practical way to help liver transplant patients stay alcohol-free, reducing the risk of liver damage and improving long-term health.
What could go wrong
This is a very small pilot study with only 30 people, so results may not apply to everyone. The rewards are modest and the effect may not last after the 10-week program ends.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Pfleger Liver Institute

    Los Angeles, California, 90095-1406, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.